Alumni

Alumni
3T Biosciences is solving major bottleneck in the field of immunotherapy - identifying
Alumni
4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy
Alumni
Accelerating the discovery of new drugs through the creation of technologies designed for
Alumni
QuickFire
Challenge Winner
At Ab Initio, we are using a proprietary directed evolution engineering technology to
Alumni
Providing technology platforms that can be tailored and applied to any disease treatable
Alumni
Achelois’ mission is to develop effective and nontoxic therapeutics to inhibit tumors, and
Alumni
Convoy’s technology platform focuses on solving major unmet needs in aesthetics and
Alumni
Adicet is developing a novell cell therapy platform.
Alumni
Targeting sensitized nerves to treat chronic & debilitating neurogenic disorders
Alumni
Agenovir is developing a novel class of nuclease-based anti-viral therapeutics for
Alumni
Alector is combining state-of-the-art antibody technology and recent discoveries in
Alumni
Amarantus BioScience Holdings (AMBS) is a biotechnology company developing treatments and
Alumni
Amplyx Pharmaceuticals Inc is a preclinical stage company that re-engineers small molecule
Alumni
Our mission is to be the leader in detecting/monitoring Alzheimer’s disease. We are